[ORGANIZATION]
Servier Group
Featured in 1 tracked story · first seen
Situations
Vorasidenib clinical development and recognition
2 clusters · 5 sources · last updated
Latest: Servier receives Prix Galien Italia for vorasidenib glioma therapy
Clinical research presented at the European Association of Neuro-Oncology congress in Rome indicated that vorasidenib achieved disease control in 96% of patients with grade 2 gliomas. This study, conducted across seven h